Pricing Log in Create free account

MediWound Ltd. (MDWD) vs NovaBridge Biosciences (NBP)

MediWound Ltd. and NovaBridge Biosciences are both Biotechnology companies. MediWound Ltd. and NovaBridge Biosciences are of similar size ($157.6M and $149.6M). MediWound Ltd. grew revenue faster over the last twelve months: −40.3% against −91.8%. NovaBridge Biosciences has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (0.00% vs −6,551.8%). Across the 17 metrics below, NovaBridge Biosciences leads on 12 and MediWound Ltd. on 5.

Valuation

Metric MDWD NBP Biotechnology median
P/E n/m n/m 8.50
P/S 12.87 5.31 9.71
P/B 4.28 0.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.94 0.64
EV/Sales 9.97 (3.81) 9.21
Earnings yield (13.50%) (38.61%) (33.15%)
Free cash flow yield (18.71%) (89.83%) (25.50%)

Profitability

Metric MDWD NBP Biotechnology median
Gross margin 15.46% 31.10% 65.16%
Operating margin (267.75%) 0.00% 0.00%
Net margin (170.10%) 0.00% 0.00%
Free cash flow margin (240.47%) 0.00% 0.00%
Return on equity (75.42%) 0.00% (56.36%)
Return on assets (29.06%) 0.00% (48.04%)
Return on invested capital (6,551.77%) 0.00% 0.00%

Growth

Metric MDWD NBP Biotechnology median
Revenue growth (TTM) (40.26%) (91.84%) 6.02%
EPS growth (last fiscal year) 30.69% (77.78%) 30.26%
Revenue growth, 5-year CAGR (4.87%) (40.00%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD NBP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 7.64 4.72
Net debt to EBITDA 2.27 2.26 0.96

Dividend

Metric MDWD NBP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MDWD NBP Biotechnology median
Market cap 157.63m 149.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack